Meet InPen

Meet the InPen smart insulin pen


InPen empowers you with actionable data you haven't had from your patients on multiple daily injections (MDI), until now.


Request info

InPen helps solve common challenges with MDI

Missing 2 doses per week can lead to an increase in A1C of up to
0.4%1
2 out of 3 of people need help calculating their doses and
60%
of doses are stacked2-4
The use of a bolus calculator is associated with a
0.7%-1%
reduction in A1C5-7
A system that makes life easier for your patients
Offer available to those with commercial insurance. Terms and conditions apply. Learn more bit.ly/35option

A system that makes life easier for your patients


InPen helps people on MDI take the right amount of insulin at the right time, thanks to real-time tracking and decision support.

✓ Tracks active insulin
✓ Reminds user to dose
✓ Calculates personalized doses
✓ Automatically logs doses
✓ Syncs with CGMs and glucose meters


Request info

Intuitive and affordable decision support


InPen helps reduce the mental burden associated with diabetes management by providing personalized dosing amounts, keeping track of injections, and offering reminders for missed doses.

Intuitive and affordable decision support

The InPen smart
insulin pen


The InPen smart insulin pen

The InPen app


The InPen app

Visibility of patient data


Advanced tracking and algorithms, along with intuitive reports, tell you and your patients more about their MDI therapy than ever before. Patients can share their InPen™ data with you at any time. See when and how much your patients are dosing, and get full visibility into their blood glucose and carb intake. At their next appointment, you can collaborate and identify new ways to help achieve their goals.

Full visibility of patient data
Example Patient Profile

Learn about InPen, a smarter diabetes management tool


Complete the form below and a sales representative will follow up with additional information.

How can we help you? Check all that apply. I would like:

How can we communicate with you?


Marketing Consent

By providing your contact information, you authorize Medtronic MiniMed, Inc. and its affiliates (“Medtronic”) to contact you. You agree we may send text messages and use automatic telephone dialing systems in connection with texts or calls made to any telephone number you provide, even if the telephone number is assigned to a cellular or mobile telephone service. You also agree that we may use your contact information to contact you on a recurring basis and send you additional information and communications related to Medtronic and its products and therapies, including for promotional and marketing purposes. You agree your consent is not a condition of purchasing any products or services from Medtronic. Message and Data Rates May Apply. You may revoke this permission at any time by emailing takecontrol@medtronic.com or by sending a request in writing to: Medtronic MiniMed, Inc., Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219

Prescription information

How to prescribe InPen?

Option 1: Prescribe through EMR

Option 2: Complete the form above or fill out the form and email it to rx@companionmedical.com or fax to 877-44-2373.

Prescription information

How to dispense InPen?

InPen is currently available to order via Cardinal, McKesson and AmerisourceBergen. InPen comes in three colors and two different models.

Learn more

Frequently asked questions


InPen is a prescription-only device. Eligible patients with commercial insurance may pay as little as $35 per prescribed InPen. Each InPen is reusable for one year. Terms and conditions apply – learn more.
You can prescribe InPen through EMR or our start order form. Learn more about how to prescribe InPen here.
If you need help adjusting your patient’s therapy mode (dose calculator) in the InPen app, please contact our technical support team at 844-843-7903, option 1.
Your patient can send their Insights Report to you directly from their InPen app. Learn more here.
Our trained InPen Specialists are available for virtual 1-on-1 training sessions Monday through Friday from 6am – 6pm PT. We ask that patients contact their healthcare provider with questions about their therapy settings, insulin regimen, or blood glucose concerns.

References
1. Randlov, J., Poulsen, J.U. J Diabetes Sci Technol. 2008 Mar; 2(2): 229-235. Published online 2008 Mar. doi: [10.1177/1932296 80800200209]
2. Garg SK, Bookout TR, McFann KK, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technology and Therapeutics. 2008; 10(5):369-375.
3. Zaugg, Stephanie D., et al. “Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.” Clinical diabetes: a publication of the American Diabetes Association 32.4 (2014): 152-157.
4. Cavanaugh, Kerri, et al. “Association of numeracy and diabetes control.” Annals of Internal Medicine 148.10 (2008): 737-746.
5. Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-3619.
6. Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care. 1999; 22(8):1252-1257.
7. Anderson DG. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatric Diabetes. 2009; 10(5):304-309.
* Humalog® is a registered trademark of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S.
† The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.

Important Safety Information: InPen
The InPen is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.

Rx only. Under age 7 requires supervision of an adult caregiver. User interaction, compatible device, proper pairing and settings required. See http://bit.ly/InPenSafety

US-DBA-2100353